Author Archives for Adeline Chauvigné

Valneva wins approval from European Commission to supply Covid-19 vaccines

Valneva, a specialty vaccine company and member of Atlanpole Biotherapies, announced that the European Commission (“EC”) has approved an agreement... View Article

Rédigé par Adeline Chauvigné, le 2021-11-16

Valneva wins approval from European Commission to supply Covid-19 vaccines

Valneva, a specialty vaccine company and member of Atlanpole Biotherapies, announced that the European Commission (“EC”) has approved an agreement... View Article

New member | AGS-M

AGS-M is a young CDMO dedicated to the development, the optimization and validation of manufacturing processes (production, clarification, purification and... View Article

Rédigé par Adeline Chauvigné, le 2021-11-03

New member | AGS-M

AGS-M is a young CDMO dedicated to the development, the optimization and validation of manufacturing processes (production, clarification, purification and... View Article

Valneva raises €88 million

Valneva, a specialty vaccine company, announced today that the underwriters of its global offering of an aggregate of 4,500,000 new... View Article

Rédigé par Adeline Chauvigné, le 2021-11-02

Valneva raises €88 million

Valneva, a specialty vaccine company, announced today that the underwriters of its global offering of an aggregate of 4,500,000 new... View Article

Innovative medical device same™ by i-SEP : promising clinical results

MedTech – Autotransfusion or IntraOperative Cell Recovery Recovery of platelets in addition to red blood cells, a world premiere Following... View Article

Rédigé par Adeline Chauvigné, le 2021-10-25

Innovative medical device same™ by i-SEP : promising clinical results

MedTech – Autotransfusion or IntraOperative Cell Recovery Recovery of platelets in addition to red blood cells, a world premiere Following... View Article

KetoM+ is launching Cétoprane, a ketogenic medical food (DADFMS)

KetoM+, member of our network based in Le Mans, is launching Cétoprane, a ketogenic medical food (DADFMS) nutritionally adapted for... View Article

Rédigé par Adeline Chauvigné, le 2021-10-18

KetoM+ is launching Cétoprane, a ketogenic medical food (DADFMS)

KetoM+, member of our network based in Le Mans, is launching Cétoprane, a ketogenic medical food (DADFMS) nutritionally adapted for... View Article

New member | Elisabeth Richard Business Development Consulting

Elisabeth Richard BD Consulting offers a business development (France and International) expertise in the fields of health and innovation having... View Article

Rédigé par Adeline Chauvigné, le 2021-10-18

New member | Elisabeth Richard Business Development Consulting

Elisabeth Richard BD Consulting offers a business development (France and International) expertise in the fields of health and innovation having... View Article

Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

VLA2001 successfully met both co-primary endpoints Superior neutralizing antibody titer levels compared to active comparator vaccine, AstraZeneca’s AZD1222 (ChAdOx1-S) Neutralizing... View Article

Rédigé par Adeline Chauvigné, le 2021-10-18

Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

VLA2001 successfully met both co-primary endpoints Superior neutralizing antibody titer levels compared to active comparator vaccine, AstraZeneca’s AZD1222 (ChAdOx1-S) Neutralizing... View Article

Owkin joins OPTIMA: new research project to improve the treatment of prostate, breast and lung cancer patients using AI

Owkin is delighted to be part of OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence),... View Article

Rédigé par Adeline Chauvigné, le 2021-11-05

Owkin joins OPTIMA: new research project to improve the treatment of prostate, breast and lung cancer patients using AI

Owkin is delighted to be part of OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence),... View Article

Hawkcell & Cynbiose team up in a strategic partnership

Cynbiose SAS, a preclinical CRO, and HawkCell, a young innovative company specialized in MRI (Magnetic Resonance Imaging) for small and... View Article

Rédigé par Adeline Chauvigné, le 2021-10-12

Hawkcell & Cynbiose team up in a strategic partnership

Cynbiose SAS, a preclinical CRO, and HawkCell, a young innovative company specialized in MRI (Magnetic Resonance Imaging) for small and... View Article

OSE Immunotherapeutics Receives New European Patent Notice of Allowance for Tedopi®

Further Strengthens Global Intellectual Property Portfolio for Tedopi® until 2038 OSE Immunotherapeutics announced today that it has received notice of... View Article

Rédigé par Adeline Chauvigné, le 2021-10-11

OSE Immunotherapeutics Receives New European Patent Notice of Allowance for Tedopi®

Further Strengthens Global Intellectual Property Portfolio for Tedopi® until 2038 OSE Immunotherapeutics announced today that it has received notice of... View Article